发明公开
EP2277919A1 Treatment with anti-ERBB2 antibodies 审中-公开
Behandlung mitAntikörperngegen ERBB2

Treatment with anti-ERBB2 antibodies
摘要:
The present invention concerns the treatment of disorders characterized by the overexpression of ErbB2. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer overexpressing ErbB2 with a combination of an anti-ErbB2 antibody and gemcitabine.
信息查询
0/0